DHT (dihydrotestosterone) contributes to hair loss in women by shrinking hair follicles through androgenetic alopecia, though estrogen often masks its effects until menopause.
DHT binds to receptors in hair follicles, shortening their growth phase and thinning hair over time. This process, called miniaturization, eventually leads to vellus hair-fine, colorless hair-or complete baldness.
In women, DHT levels rise during perimenopause and menopause due to declining estrogen, which normally counteracts DHT's effects. This explains why many women first notice hair loss in their 50s or 60s.
| Type | Cause | Typical Age Range |
|---|---|---|
| Androgenetic alopecia | Genetics + DHT sensitivity | 20s-90s (worse after menopause) |
| Telogen effluvium | Stress, illness, or medication | Any age |
| Alopecia areata | Autoimmune attack | Teen years onward |
Unlike telogen effluvium (temporary shedding from stress) or alopecia areata (patchy immune-related loss), DHT-driven hair loss progresses gradually and permanently without treatment.
A common misconception is that only men experience DHT-related hair loss. While men have higher DHT levels, women with polycystic ovary syndrome (PCOS) may also develop male-pattern baldness due to elevated androgens.
I've seen clients regain noticeable density within six months of consistent minoxidil use combined with nutritional support (iron, zinc, and biotin). However, results vary based on underlying causes and treatment adherence.
Consult a dermatologist if hair loss exceeds 100 hairs/day, appears suddenly, or includes scalp redness/itching. Blood tests can check for PCOS, thyroid disorders, or vitamin deficiencies that may contribute to hair loss.
According to the American Academy of Dermatology, about 30 million women in the U.S. experience some form of hair loss. Early intervention improves outcomes, especially for DHT-related cases.